• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
OIG Sheds Light on Kickback Implications of Online Healthcare Directories

OIG Sheds Light on Kickback Implications of Online Healthcare Directories

by Glenn S. Demby | Aug 29, 2023 | Essential, National Lab Reporter, OIG-nir

Recent advisory opinion offers insight on how healthcare providers may want to structure arrangements involving online directories.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments

Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments

by Glenn S. Demby | Aug 24, 2023 | Enforcement-nir, Essential, National Lab Reporter

Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
July 2023 Enforcement Roundup

July 2023 Enforcement Roundup

by Rachel Muenz | Jul 4, 2023 | Enforcement-lca, Essential, Lab Compliance Advisor

Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
OIG Semi-Annual Report Calls Out Drug, Genetic, and COVID-19 Testing Fraud

OIG Semi-Annual Report Calls Out Drug, Genetic, and COVID-19 Testing Fraud

by Glenn S. Demby | Jun 29, 2023 | Enforcement-nir, Essential, National Lab Reporter

These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Compliance Alert: OIG Sounds the Alarm on Medicare Overpayments for Physician Services Provided to Inpatients

Compliance Alert: OIG Sounds the Alarm on Medicare Overpayments for Physician Services Provided to Inpatients

by Glenn S. Demby | Jun 28, 2023 | Essential, National Lab Reporter, OIG-nir

According to a recent report, Medicare overpaid for such services over a two-year period between 2019 and 2020.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com